America's Health Rankings, United Health Foundation Logo
2025 Annual Report

Health Outcomes

Download
Previous Page5 / 68Next Page
Close
Executive BriefForewordIntroductionNational SnapshotFindingsHealth OutcomesSocial and Economic FactorsPhysical EnvironmentClinical CareSpotlight: Rural CommunitiesBehaviorsState RankingsInternational ComparisonAppendixMeasures TableData Source DescriptionsMethodologyReferencesState SummariesUS SummaryAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
2025 Annual Report2025 Annual Report – Executive Brief2025 Annual Report – State Summaries2025 Annual Report – Economic Hardship Index County-Level Maps2025 Annual Report – Measures Table2025 Annual Report – Infographics2025 Annual Report – Report Data (All States)
‌‌‌‌‌
‌
‌
‌‌‌
‌
‌

Please tell us a little more about you

We appreciate you taking the time to help America’s Health Rankings better understand our audiences. Your feedback will allow us to optimize our website and provide you with additional resources in the future. Thank you.

Please select one option which best describes your profession or field of expertise

Journalist or media professional
Health Policy Professional
Public health professional (state, local, or community level)
Health care provider or administrator
Member of an advocacy group or trade organization
Academic, student, or researcher
Government administrator, legislator, or staffer
Concerned citizen
Other
Don't show me this again

Behavioral Health

Drug Deaths

Drug overdose deaths in the United States decreased
external-link
between 2022 and 2023, after two decades of near-continuous increases.2 Provisional 2024 data
external-link
suggest that this positive trend is continuing.3 However, not all regions, racial/ethnic groups or age groups experienced improvements
external-link
in overall drug deaths.4
Changes over time. Nationally, the drug death rate decreased 3% from 32.4 to 31.4 deaths due to drug injury (unintentional, suicide, homicide or undetermined) per 100,000 population between 2022 and 2023. This rate still exceeds the Healthy People 2030 target to reduce drug overdose deaths to 20.7 deaths per 100,000 population
external-link
.5 In 2023, 105,000 people in the U.S. died of a drug overdose, 2,900 fewer deaths than in 2022. 
Between 2022 and 2023, the drug death rate significantly decreased:
  • 11% among those ages 15-24 (15.1 to 13.5 deaths per 100,000 population), 10% among those ages 25-34 (50.6 to 45.6), and 4% among both those ages 35-44 (63.1 to 60.8) and those ages 45-54 (55.3 to 53.3).
  • 6% among white populations (34.6 to 32.6).
  • 5% among females (19.1 to 18.2) and 2% among males (45.9 to 44.8).
However, during the same period, the drug death rate significantly increased:
  • 12% among those ages 65-74 (19.0 to 21.3 deaths per 100,000 population).
  • 3% among Black populations (49.3 to 50.9).
Graphic representation of Drug Deaths by Age information contained on this page. Download the full report PDF from the report Overview page for details.
Between 2022 and 2023, the drug death rate significantly decreased in 14 states, but increased in five states. The largest decreases were: 19% in North Carolina (40.3 to 32.5 deaths per 100,000 population), 17% in both Arkansas (20.3 to 16.8) and Indiana (39.3 to 32.7), and 16% in Maine (51.0 to 42.8). The drug death rate increased 41% in Alaska (34.6 to 48.9), 31% in Oregon (32.1 to 42.1), 27% in both Washington (35.0 to 44.5) and Nevada (31.6 to 40.1), and 4% in California (28.1 to 29.2).
Graphic representation of Drug Deaths By Race/Ethnicity in 2023 information contained on this page. Download the full report PDF from the report Overview page for details.

Differences. The drug death rate significantly varied by race/ethnicity, geography, age and gender in 2023. The rate was: 
  • 11.8 times higher among American Indian/Alaska Native (63.6 deaths per 100,000 population) compared with Asian (5.4) populations.
  • 8.9 times higher in West Virginia (77.8) than in Nebraska (8.7).
  • 4.5 times higher among those ages 35-44 (60.8) than those ages 15-24 (13.5).
  • 2.5 times higher among males (44.8) compared with females (18.2).
Related Measure: Non-Medical Drug Use
Nationally, the percentage of adults who reported using prescription drugs non-medically (including pain relievers, stimulants and sedatives) or illicit drugs (excluding cannabis) in the last 12 months did not change significantly between 2024 and 2025 (17.6% to 16.8%). In 2025, almost 44.2 million adults reported non-medical drug use. Over the longer term, non-medical drug use increased 49% from 11.3% to 16.8% between 2019 and 2025.
Between 2024 and 2025, non-medical drug use prevalence significantly decreased:
  • 9% among adults with incomes of $75,000 or more (11.2% to 10.2%).
  • 9% among college graduates (19.7% to 18.0%).
  • 8% among white adults (17.9% to 16.5%). 
During the same period, non-medical drug use significantly changed in one state. Use decreased 37% in Nevada (39.3% to 24.9%).

Excessive Drinking

Excessive alcohol use is one of the leading preventable causes of death in the U.S., causing an estimated 178,000 deaths
external-link
every year, behind tobacco use and poor diet/physical inactivity.6 Excessive drinking can lead to alcohol poisoning
external-link
, unintentional injuries
external-link
, hypertension
external-link
, heart disease
external-link
, stroke, liver disease, several different cancers and alcohol use disorder
external-link
.7–11
Changes over time. Nationally, the percentage of adults who reported excessive drinking remained stable (16.7% to 17.0%) between 2023 and 2024. Excessive drinking includes both binge drinking (four or more drinks on one occasion in the past 30 days for females or five or more for males) and heavy drinking (eight or more drinks per week for females or 15 or more for males). Long-term, the prevalence decreased 14% (from 19.8%) between 2011 and 2024.
Between 2023 and 2024, excessive drinking prevalence significantly decreased 15% in Hawaii (20.1% to 17.1%). During the same time period, the prevalence significantly increased 10% among adults age 65 and older (6.9% to 7.6%) and 7% among adults ages 45-64 (15.1% to 16.2%).
Differences. Excessive drinking significantly varied by age, geography, race/ethnicity, disability status, income, gender, sexual orientation and educational attainment. In 2024, the prevalence was:
  • 2.9 times higher among adults ages 18-44 (21.9%) compared with those age 65 and older (7.6%).
  • 2.3 times higher in the District of Columbia (27.2%) and 1.9 times higher in Montana (22.5%) than in Utah (11.9%).
  • 2.0 times higher among multiracial (19.1%) than Asian (9.7%) adults.
  • 1.9 times higher among adults who have difficulty with cognition (18.7%) compared with adults who have difficulty with mobility (9.9%).
  • 1.8 times higher among adults with an annual household income of $150,000 or more (22.3%) than those with incomes less than $25,000 (12.6%).
  • 1.6 times higher among men (20.5%) than women (13.1%).
  • 1.3 times higher among lesbian, gay, bisexual and queer (LGBQ+) (21.4%) than straight (16.2%) adults.
  • 1.1 times higher among college graduates (16.5%) than adults with less than a high school education (14.9%).
Note: No data were available for Tennessee in 2024 or for Kentucky and Pennsylvania in 2023. The values for multiracial (19.1%), Hispanic (17.9%), white (17.7%), Hawaiian/Pacific Islander (17.0%) and American Indian/Alaska Native (15.6%) adults may not differ significantly based on overlapping 95% confidence intervals. The same is true for adults who have difficulty with cognition (18.7%) and those without a disability (17.6%); adults who have difficulty with mobility (9.9%) and adults who have difficulty with self-care (11.3%); and college graduates (16.5%), adults with some post-high school education (16.1%) and high school graduates (16.1%). Disability groups are not mutually exclusive.

Suicide

Suicide is a troubling public health issue that leaves a lasting impact
external-link
on families and communities.12 In 2024, 14.3 million
external-link
adults seriously thought about suicide, 4.6 million made a plan and 2.2 million attempted suicide.13
Changes over time. Nationally, the suicide rate did not significantly change between 2022 and 2023 (14.8 to 14.7 deaths due to intentional self-harm per 100,000 population) and remains higher than the Healthy People 2030 target to reduce the suicide rate to 12.8 deaths per 100,000 population
external-link
.14 In 2023, more than 49,300 suicide deaths occurred in the U.S. Long-term, the suicide rate increased 23% from 12.0 to 14.7 between 2009 and 2023.
Differences. The suicide rate significantly varied by geography, gender, race/ethnicity and age in 2023. The rate was:
  • 4.7 times higher in Alaska (28.1 deaths per 100,000 population) than in the District of Columbia (6.0), and 3.7 times higher in Alaska than in New Jersey (7.6). ​
  • 3.9 times higher among males (23.6) compared with females (6.1).​
  • 3.5 times higher among American Indian/Alaska Native (23.7) than Asian (6.8) populations.​
  • 1.7 times higher among those age 85 and older (22.7) than those ages 15-24 (13.5).​
Related Measure: Frequent Mental Distress
Nationally, the percentage of adults who reported their mental health was not good 14 or more days in the past 30 days remained stable nationally (15.4% to 15.6%) and significantly increased in one state between 2023 and 2024 (Wisconsin, 14.7% to 17.2%). However, since 2011, the prevalence of frequent mental distress has increased 33% nationally (from 11.7%). 

Mortality

Premature Death
Graphic representation of Premature Death By Race/Ethnicity in 2021-2023 information contained on this page. Download the full report PDF from the report Overview page for details.

Premature death is a measure of years of potential life lost due to death occurring before the age of 75. Deaths at younger ages contribute more to the premature death rate than deaths occurring closer to age 75. For example, a person dying at age 70 would lose five years of potential life, whereas a child dying at age five would lose 70 years of potential life. The top five causes
external-link
of premature death in 2023 were unintentional injuries, cancer, heart disease, suicide and homicide.15 In 2023, homicide replaced COVID-19 in the top five and COVID-19 dropped out of the top 10
external-link
.16
Changes over time. Nationally, premature death decreased 8% from 8,522 to 7,862 years lost before age 75 per 100,000 population between 2022 and 2023. During this time frame, the premature death rate decreased in 44 states, led by: 13% in Maine (9,327 to 8,082), 12% in both South Dakota (9,120 to 8,047) and West Virginia (13,647 to 12,053), and 11% in both Indiana (10,167 to 9,093) and Missouri (10,446 to 9,303).
Differences. The premature death rate varied by race/ethnicity and geography. It was: 
  • 5.0 times higher among American Indian/Alaska Native (16,918 years lost before age 75 per 100,000) compared with Asian (3,369) populations in 2021-2023.
  • 2.1 times higher in Mississippi (12,071) than in Massachusetts (5,760) in 2023.
Graphic representation of Premature Death information contained on this page. Download the full report PDF from the report Overview page for details.

Physical Health

Multiple Chronic Conditions
Graphic representation of Chronic Conditions In 2024 information contained on this page. Download the full report PDF from the report Overview page for details.

Chronic conditions
external-link
are health conditions lasting more than a year that require ongoing medical attention and/or limit daily functions such as eating, bathing and mobility.17 The more chronic conditions an individual has, the higher their risk
external-link
of physical, social and cognitive limitations, longer hospital stays
external-link
, adverse drug events
external-link
and mortality.17–19
Changes over time. Nationally, the percentage of adults who have three or more of these chronic conditions — arthritis, asthma, cancer (excluding nonmelanoma skin cancer), cardiovascular diseases (heart disease, heart attack or stroke), chronic kidney disease, chronic obstructive pulmonary disease (COPD), depression or diabetes — increased 6% from 10.7% to 11.3% of adults between 2023 and 2024. During this time arthritis increased 4% (26.3% to 27.3%), asthma increased 6% (10.3% to 10.9%), cancer increased 4% (8.4% to 8.7%), cardiovascular diseases increased 8% (8.5% to 9.2%), chronic kidney disease increased 8% (3.7% to 4.0%), COPD increased 2% (6.4% to 6.5%) and diabetes increased 4% (11.5% to 12.0%). Depression was the only chronic condition that did not change, remaining at 22.0% in 2024.
Between 2023 and 2024, the prevalence of multiple chronic conditions significantly increased:
  • 17% among adults ages 18-44 (3.0% to 3.5%), 12% among those ages 45-64 (12.3% to 13.8%) and 5% among those age 65 and older (22.2% to 23.2%).
  • 16% among adults without a disability (4.5% to 5.2%), 8% among those who have difficulty hearing (28.3% to 30.7%) and 7% among those who have difficulty with cognition (23.7% to 25.4%).
  • 12% among both adults with some post-high school education (13.5% to 15.1%) and college graduates (7.3% to 8.2%).
  • 12% among adults with incomes of $50,000 to $74,999 (11.3% to 12.7%) and 8% among those with incomes of $25,000 to $49,999 (15.3% to 16.5%).
  • 11% among straight adults (10.8% to 12.0%).
  • 9% among adults living in metropolitan areas (9.7% to 10.6%) and 7% among adults living in nonmetropolitan areas (14.4% to 15.4%).
  • 9% among adults who have not served in the U.S. armed forces (9.8% to 10.7%).
  • 8% among white adults (12.2% to 13.2%).
  • 8% among both women (12.2% to 13.2%) and men (8.6% to 9.3%).
During this time frame, the prevalence of multiple chronic conditions significantly increased in six states, with the largest increases being 24% in Texas (8.3% to 10.3%), 20% in Michigan (12.8% to 15.3%), and 17% in both Nebraska (8.4% to 9.8%) and Oklahoma (12.8% to 15.0%). 
Graphic representation of Multiple Chronic Conditions By Race/Ethnicity in 2024 information contained on this page. Download the full report PDF from the report Overview page for details.
Differences. The prevalence of multiple chronic conditions significantly varied by disability status, age, race/ethnicity, income, geography, educational attainment, veteran status, metropolitan status, gender and sexual orientation in 2024. It was:
  • 8.8 times higher among adults who have difficulty with self-care (45.8%) than those without a disability (5.2%).
  • 6.6 times higher among adults age 65 and older (23.2%) compared with those ages 18-44 (3.5%).
  • 5.2 times higher among American Indian/Alaska Native (16.5%) compared with Asian (3.2%) adults.
  • 4.7 times higher among adults with an annual household income less than $25,000 (23.3%) compared with those with incomes of $150,000 or more (5.0%).
  • 2.5 times higher in West Virginia (20.6%) than in California (8.1%).
  • 2.0 times higher among adults with less than a high school education (16.6%) than college graduates (8.2%).
  • 1.6 times higher among adults who have served in the U.S. armed forces (17.4%) than those who have not served (10.7%).
  • 1.5 times higher among adults living in nonmetropolitan areas (15.4%) than those in metropolitan areas (10.6%).
  • 1.4 times higher among women (13.2%) compared with men (9.3%).
  • 1.2 times higher among straight (12.0%) compared with LGBQ+ (10.4%) adults.
Note: No data were available for Tennessee in 2024 or for Kentucky and Pennsylvania in 2023. The values for American Indian/Alaska Native (16.5%), other race (15.1%), multiracial (15.0%) and Hawaiian/Pacific Islander (11.0%) adults may not differ significantly based on overlapping 95% confidence intervals.
Related Measure: Obesity
After increasing 23% between 2011 and 2023 (27.8% to 34.3%), the national obesity prevalence among adults remained stable between 2023 and 2024 at 34.2%. The prevalence did not significantly change in any states during this recent period, but it did significantly increase 4% among adults ages 18-44, from 30.0% to 31.3%.
Note: No data were available for Tennessee in 2024 or for Kentucky and Pennsylvania in 2023.
America's Health Rankings, United Health Foundation Logo

Reports

Partner With Us

Explore the Data and Stay Tuned for New Insights

Want to be notified of our latest updates? Sign up now

America's Health Rankings, United Health Foundation Logo